Viewing StudyNCT05160922



Ignite Creation Date: 2024-05-06 @ 5:00 PM
Last Modification Date: 2024-10-26 @ 2:20 PM
Study NCT ID: NCT05160922
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-26
First Post: 2021-12-06

Brief Title: Crizotinib Continuation Clinical Study
Sponsor: Pfizer
Organization: Pfizer

Conditions & Keywords Data

Conditions:
Name
IMT
NSCLC
ALCL
Keywords:
Name View
crizotinib View
Xalkori View
Anaplastic Lymphoma Kinase View
ALK View
ROS1 View
NSCLC View
Non-small Cell Lung Cancer View
ALCL View
anaplastic large cell lymphoma View
IMT View
inflammatory myofibroblastic tumour View